As new omicron subvariants of COVID-19 continue to sweep across the United States, researchers at the University of Missouri have identified specific mutations within the virus' spike protein that help omicron subvariants ...
Jul 18, 2022
0
60
Research led by Suresh Alahari, Ph.D., Professor of Biochemistry at LSU Health New Orleans schools of Medicine and Graduate Studies, suggests a combination of drugs already approved by the FDA for other cancers may be effective ...
Jun 29, 2022
0
39
Army scientists determined that the body's own natural immune response contributes to disease severity in mice infected with Crimean-Congo hemorrhagic fever virus (CCHFV), which causes a widespread tick-borne viral infection ...
May 20, 2022
0
19
New research on the experimental drug NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the ...
May 17, 2022
0
71
Based on the findings of a new study led by the Translational Genomics Research Institute (TGen), part of City of Hope, a coast-to-coast clinical trial is planned that, if successful, could lead to FDA approval of the first ...
May 3, 2022
0
70
Vijoice (alpelisib) has been granted accelerated approval for severe PIK3CA-related overgrowth spectrum (PROS), the U.S. Food and Drug Administration announced April 6.
Apr 19, 2022
0
2
The U.S. Medicare program's decision to tightly limit coverage for the first drug meant to slow the course of Alzheimer's disease has raised the stakes for companies trying to make the next one.
Apr 11, 2022
0
2
In its first year of implementation, the RACE Act has resulted in increased requirements for more recently approved cancer drugs to be studied for potential use in pediatric patients, according to data presented at the AACR ...
Apr 11, 2022
0
3
After the Food and Drug Administration approved Pfizer-BioNTech's COVID-19 vaccine in August, public health experts were hopeful vaccine uptake would skyrocket.
Apr 6, 2022
0
11
Researchers have engineered probiotic bacteria that can synthesize the dopamine precursor L-DOPA, a powerful mainstay treatment for Parkinson's disease. Preclinical tests show that the new treatment approach is not only safe ...
Apr 1, 2022
0
45
